Evidence map›Paper›PMID 36596670›Full record

ReviewRNA (New York, N.Y.)2023

Z-RNA biology: a central role in the innate immune response?

Parker J Nichols, Jeffrey B Krall, Morkos A Henen, Beat Vögeli, Quentin Vicens

Open access · bronzeAbstract readReview
In one paragraph

Review in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Cromolyn as a novel pharmacophore of the Zα domain of the RNA-editing enzyme ADAR1p150.Protein science : a publication of the Protein Society · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Solution Structure of Poly(UG) RNA.Journal of molecular biology · 2023
    Article
  16. The Z-nucleic acid sensor ZBP1 in health and disease.The Journal of experimental medicine · 2023
    Article
  17. Review
  18. Article
  19. Structure and Formation of Z-DNA and Z-RNA.Molecules (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Parker J NicholsDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado 80045, USA.ORCID 0000-0003-1930-6408
Jeffrey B KrallDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado 80045, USA.ORCID 0000-0001-9179-0623
Morkos A HenenDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado 80045, USA.ORCID 0000-0003-4835-5583
Beat VögeliDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado 80045, USA quentin.vicens@cuanschutz.edu beat.vogeli@cuanschutz.edu.ORCID 0000-0003-1176-3137
Quentin VicensDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado 80045, USA quentin.vicens@cuanschutz.edu beat.vogeli@cuanschutz.edu.ORCID 0000-0003-3751-530X
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · USMansoura University · EG

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
600 MHz NMR console and cold probeS10OD025020 · OD · UNIVERSITY OF COLORADO DENVER · PI JONES, DAVID NIGEL · 2018 to 2018
$501k
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1R21AI171827 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENEN, MORKOS, STECKELBERG, ANNA-LENA · 2022 to 2023
$458k
A-Z junction formation drives recognition of Alu RNAs by ADAR1 and supports viral infectivity and replicationF31AI167396 · NIAID · UNIVERSITY OF COLORADO DENVER · PI NICHOLS, PARKER J · 2022 to 2024
$109k
NIAID NIH HHS F31 AI167396
6 · The paper itself

Abstract

Z-RNA is a higher-energy, left-handed conformation of RNA, whose function has remained elusive. A growing body of work alludes to regulatory roles for Z-RNA in the immune response. Here, we review how Z-RNA features present in cellular RNAs-especially containing retroelements-could be recognized by a family of winged helix proteins, with an impact on host defense. We also discuss how mutations to specific Z-contacting amino acids disrupt their ability to stabilize Z-RNA, resulting in functional losses. We end by highlighting knowledge gaps in the field, which, if addressed, would significantly advance this active area of research.

Indexed as

DNA, Z-FormRNAAdenosine DeaminaseAmino AcidsBiologyImmunity, InnateAdenosine DeaminaseAmino AcidsDNA, Z-FormRNAadenosine deaminase acting on RNA (ADAR1)E3Linnate immune responseretroelementZ-D/RNA-binding protein 1 (ZBP1)Z-RNAZα

Identifiers

PMID36596670
PMCPMC9945438
OpenAlexW4313458213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.